Comparative Effectiveness of mRNA and Inactivated Whole-Virus Vaccines Against Coronavirus Disease 2019 Infection and Severe Disease in Singapore.

Autor:	Premikha, M, Chiew, Calvin J, Wei, Wycliffe E, Leo, Yee Sin, Ong, Benjamin, Lye, David Chien, Lee, Vernon J, Tan, Kelvin Bryan
Předmět:	RELATIVE medical risk COVID-19 CONFIDENCE intervals COVID-19 vaccines DISEASE incidence REGRESSION analysis VACCINE effectiveness SEVERITY of illness index MESSENGER RNA OXYGEN therapy SOCIAL classes STATISTICAL models DATA analysis software POISSON distribution
Zdroj:	Clinical Infectious Diseases; 10/15/2022, Vol. 75 Issue 8, p1442-1445, 4p
Abstrakt:	Compared with individuals vaccinated with Pfizer-BioNTech/Comirnaty, recipients of Sinovac-CoronaVac and Sinopharm were 2.37 (95% CI, 2.29–2.46) and 1.62 (95% CI, 1.43–1.85) times more likely to be infected with coronavirus disease 19, respectively, while individuals vaccinated with Moderna were 0.42 (95% CI, 0.25–0.70) times less likely to develop severe disease. [ABSTRACT FROM AUTHOR]
Databáze:	Complementary Index
Externí odkaz:	Zobrazit plný text záznamu